Procure lab-tested compounds, bio-active peptides, and pharmaceutical raw materials directly from audited cGMP manufacturing facilities with complete HPLC and MS validation.
An authoritative technical review of molecular attributes, physicochemical properties, and baseline analytical standards for industrial procurement officers and pharmaceutical chemical engineers.
4′-Methylpropiophenone (systematic IUPAC nomenclature: 1-(4-methylphenyl)propan-1-one, commonly designated under CAS Registry Number 5337-93-9) is an essential aromatic ketone serving as an indispensable precursor and building block in both pharmaceutical active pharmaceutical ingredient (API) synthesis and specialized polymer manufacturing. Characterized by a benzene ring substituted at the para-position with a methyl functional group and conjugated with a propionyl moiety, this intermediate exhibits exceptional electrophilic and nucleophilic reactivity across the carbonyl and α-carbon positions.
In the contemporary specialty chemical market, commercial sourcing of 4′-Methylpropiophenone requires rigorous chemical characterization to prevent isomeric cross-contamination (particularly ortho- and meta-methylpropiophenone isomers). When purchasing from high-capacity manufacturing facilities, procurement directors must evaluate analytical integrity through gas chromatography coupled with flame ionization detection (GC-FID) and liquid chromatography-mass spectrometry (LC-MS) to guarantee high-yield downstream synthesis.
| Analytical Parameter | Standard Specification | Tested Laboratory Result | Testing Methodology |
|---|---|---|---|
| Chemical Name | 1-(4-Methylphenyl)propan-1-one | Conforms to Structure | 1H-NMR & 13C-NMR Spectroscopy |
| CAS Registry Number | 5337-93-9 | 5337-93-9 | CAS Substance Registry Validation |
| Molecular Formula & Weight | C10H12O | 148.20 g/mol | 148.20 g/mol | High-Resolution Mass Spec (HRMS) |
| Physical Appearance | Clear, colorless to faint pale-yellow liquid | Colorless mobile liquid | Visual Inspection (USP 〈631〉) |
| Assay Purity (GC) | ≥ 99.50% (Area normalization) | 99.82% | GC-FID (Capillary Column DB-5MS) |
| Density (20°C) | 0.993 ± 0.005 g/cm³ | 0.994 g/cm³ | Digital Density Meter (ASTM D4052) |
| Boiling Point | 238.0 – 239.0 °C at 760 mmHg | 238.4 °C | Thermal Equilibrium Distillation |
| Melting / Freezing Point | 7.0 – 7.5 °C | 7.2 °C | Differential Scanning Calorimetry (DSC) |
| Refractive Index (n20/D) | 1.527 – 1.530 | 1.5285 | Abbe Refractometry |
| Moisture Content (KF) | ≤ 0.10% (w/w) | 0.04% | Coulometric Karl Fischer Titration |
| Free Acidity (as Propionic Acid) | ≤ 0.05% | 0.015% | Potentiometric Neutralization Titration |
In-depth analysis of regional production hubs, trade route resilience, regulatory pressures, and raw material feedstock dependency across international supply lanes.
Over 72% of merchant 4′-Methylpropiophenone is synthesized within dedicated fine-chemical corridors across East Asia, notably in Shandong, Hebei, and Jiangsu provinces, with secondary advanced distillation capacity located in Gujarat, India, and specialized batch custom synth houses in Central Europe. The concentration of upstream toluene refiners and propionic acid petrochemical complexes provides these regions with distinct economies of scale.
Valued at approximately USD 142 Million in 2023, the international trade volume of high-purity CAS 5337-93-9 is projected to expand at an estimated Compound Annual Growth Rate (CAGR) of 5.8% through 2032. Primary structural drivers include exponential demand for modern UV-curable industrial photopolymers in additive manufacturing, alongside expanding regional production of therapeutic anti-spasmodic active pharmaceuticals in developing healthcare markets.
Because of structural similarities to specialized synthetic precursors, 4′-Methylpropiophenone is subject to targeted compliance tracking under international chemical diversion frameworks. Tier-one factories mandate verifiable End-User Declarations (EUD), verifiable corporate tax credentials, and rigorous KYC verification protocols to maintain fully compliant export documentation with customs organizations worldwide.
The manufacturing cost structure of 4′-Methylpropiophenone is deeply tied to the volatility of base aromatics and propionic derivatives. Toluene pricing correlates directly with crude oil cracking margins, while propionyl chloride is influenced by elemental chlorine supply chains and glacial propionic acid dynamics. Industrial buyers mitigate these market shifts by entering into annual take-or-pay indexed supply contracts directly with integrated manufacturing plants, avoiding intermediary distributor markups and erratic spot-market pricing.
From centrally acting skeletal muscle relaxants to high-throughput UV curing photoinitiators: how modern industries leverage high-purity CAS 5337-93-9.
The primary pharmaceutical application of 4′-Methylpropiophenone is serving as the key starting raw material for synthesizing Tolperisone Hydrochloride (a centrally acting muscle relaxant used for spasticity, neurological diseases, and lumbar spondylosis). The reaction involves Manneth reaction condensation with formaldehyde and piperidine, requiring exceptionally low ortho-isomer content (<0.1%) to prevent unfilterable byproduct impurities.
In the advanced radiation-curing sector, CAS 5337-93-9 is functionalized into Type I and Type II ultraviolet (UV) photoinitiators (such as 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one analogues). These specialty photo-initiators are critical for curing photopolymer resins in stereolithography (SLA) 3D printing, advanced optical fiber exterior coatings, flexographic inks, and microelectronic semiconductor passivations.
Due to its pleasant floral-sweet aromatic undertones when ultra-purified, derivatives of 4′-methyl aromatic ketones are utilized in boutique fragrance compounding as fixatives for detergents and specialty household formulations. Additionally, synthetic laboratories employ it as a stereoselective platform for synthesizing chiral aryl carbinols via asymmetric ketone reduction.
Electrochemical research utilizes halogenated and Mannich derivatives of 4′-Methylpropiophenone as high-efficiency pickling inhibitors for low-carbon steel within severe acidic environments. The conjugated ketone forms a hydrophobic coordinate-covalent protective film over iron metal matrices, reducing rust formation in maritime transport and oil-gas pipelines.
A rigorous review of industrial Friedel-Crafts acylation, continuous-flow microreactor engineering, and rigorous analytical quality control methodologies.
The standard industrial synthesis of 4′-Methylpropiophenone relies on the electrophilic aromatic acylation of toluene utilizing propionyl chloride or propionic anhydride in the presence of an anhydrous Lewis acid catalyst, conventionally aluminum trichloride (AlCl3):
Because the methyl substituent on the benzene ring is an ortho/para-directing activating group, steric hindrance inherently favors substitution at the para position. Nevertheless, conventional batch-reactor configurations inevitably generate between 1.5% and 3.0% of the unwanted ortho-isomer (2′-methylpropiophenone). Modern industrial synthesis facilities suppress the formation of the ortho-isomer by maintaining strict cryogenic temperatures (-5°C to 0°C) during the initial dosing of the acylating agent, followed by controlled isothermal maturation.
Leading chemical manufacturers are rapidly abandoning traditional 5,000-liter glass-lined batch kettles in favor of continuous-flow silicon carbide (SiC) microreactors. This continuous flow approach provides several transformative process engineering advantages:
Following aqueous quenching, phase separation, and solvent stripping, crude 4′-Methylpropiophenone undergoes multi-stage fractional distillation under high vacuum (≤ 5 mmHg). Thin-film evaporators and structured packing columns with ≥ 45 theoretical plates ensure complete separation of residual toluene, propionic acid traces, and closely boiling isomer fractions, producing high-purity water-white finished liquid.
Every commercial production lot is analyzed using an Agilent 8890 GC system with a 30m × 0.25mm × 0.25μm HP-5 capillary column. Ramp rates: 80°C initial hold for 2 min, 15°C/min up to 280°C. Carrier gas: Ultra-pure Helium at 1.2 mL/min. Injector split ratio: 50:1. The system confirms ≥99.5% area purity and ensures ortho-isomer detection remains strictly below 0.10%.
Excessive water content causes uncontrolled hydrolysis in downstream organometallic reactions (such as Grignard additions) and degrades sensitive Mannich catalysts. Utilizing coulometric Karl Fischer reagents with automated diaphragm cells, water concentrations are verified at ≤ 0.05% (500 ppm), safeguarding process yields for pharmaceutical manufacturers.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) screens finished batches for residual catalysts (Al, Fe, Zn ≤ 10 ppm total). Trace organic halides resulting from propionyl chloride exchange are tested via microcoulometry to guarantee adherence to rigorous international pharmaceutical raw material limits (USP 〈232〉 and ICH Q3D guidelines).
Transitioning from traditional stoichiometric Lewis acid waste streams to heterogeneous recyclable zeolites and Zero Liquid Discharge (ZLD) chemical operations.
Traditional acylation consumes 1.1 to 1.3 equivalents of anhydrous AlCl3, resulting in vast volumes of corrosive aluminum hydroxide sludge upon aqueous workup. Modern sustainable synthesis facilities are pioneering H-Beta zeolites and sulfated zirconia (SO42-/ZrO2) catalysts in fixed-bed reactors. These heterogeneous catalysts are calcined and reused for up to 12 cycles without loss of para-isomer selectivity.
Rather than neutralizing acidic off-gases with sodium hydroxide (generating heavy sodium chloride brine waste), tier-one chemical manufacturers utilize dual-stage falling-film adiabatic absorbers. Evolved anhydrous HCl is captured directly into demineralized water to generate commercial-grade 32% aqueous hydrochloric acid for internal municipal wastewater treatment neutralization.
Green chemistry protocols eliminate chlorinated solvents (such as dichloromethane or 1,2-dichloroethane). Instead, an excess of purified toluene serves simultaneously as both reactant and benign solvent matrix. Unreacted toluene is continuously flashed off under mild vacuum and recycled back into the primary feed line, yielding an atom economy exceeding 88%.
Ensuring cargo integrity from factory synthesis floor to overseas discharge ports through certified UN-rated containers and climate-monitored supply lines.
Standard packaging formats engineered to prevent photochemical oxidation and moisture intrusion:
4′-Methylpropiophenone has a freezing point of approximately 7.2°C. In temperate and cold winter conditions, crystallization may occur naturally within containers without impacting product quality:
Full regulatory compliance across shipping documentation:
Direct, verified answers to the technical, legal, and operational questions most frequently evaluated by procurement managers, process chemists, and import compliance officers.
Explore the complete portfolio of bio-active peptides, cofactors, APIs, and specialized reference compounds with guaranteed batch-to-batch consistency and global door-to-door delivery logistics.